Skip to content
PubMed This is a summary of 94 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 94 referenced papers

Top Authors

Colin Berry
Golden Jubilee National Hospital
C. Noel Bairey Merz
Cedars-Sinai Medical Center
Hiroaki Shimokawa
Tohoku University
Carl J. Pepine
University of Florida
Janet Wei
Cedars-Sinai Medical Center
Keith G. Oldroyd
Golden Jubilee National Hospital
Margaret McEntegart
Golden Jubilee National Hospital
Alex McConnachie
University of Glasgow
Novalia Sidik
Golden Jubilee National Hospital
Tara Sedlak
University of British Columbia

Top Institutions

Ranked by publications Top 10 institutions

References

References (94)
  1. 1

    Cardiac MR enables diagnosis in 90% of patients with acute chest pain, elevated biomarkers and unobstructed coronary arteries.

    Emrich T, Emrich K, Abegunewardene N, et al.

    The British journal of radiology 2015; (88(1049)):20150025 doi:10.1259/bjr.20150025.

    PMID: 25782462
  2. 2

    Impact of comorbidities by age on symptom presentation for suspected acute coronary syndromes in the emergency department.

    Burke LA, Rosenfeld AG, Daya MR, et al.

    European journal of cardiovascular nursing 2017; (16(6)):511-521 doi:10.1177/1474515117693891.

    PMID: 28198635
  3. 3

    Utility of the History and Physical Examination in the Detection of Acute Coronary Syndromes in Emergency Department Patients.

    Dezman ZD, Mattu A, Body R

    The western journal of emergency medicine 2017; (18(4)):752-760 doi:10.5811/westjem.2017.3.32666.

    PMID: 28611898
  4. 4

    Pharmacologic Treatment of Patients With Myocardial Ischemia With No Obstructive Coronary Artery Disease.

    Turgeon RD, Pearson GJ, Graham MM

    The American journal of cardiology 2018; (121(7)):888-895 doi:10.1016/j.amjcard.2017.12.025.

    PMID: 29394999
  5. 5

    Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.

    Corcoran D, Young R, Adlam D, et al.

    International journal of cardiology 2018; (266()):7-14 doi:10.1016/j.ijcard.2018.04.061.

    PMID: 29716756
  6. 6

    Editor's Choice- Pathophysiology, diagnosis and management of MINOCA: an update.

    Scalone G, Niccoli G, Crea F

    European heart journal. Acute cardiovascular care 2019; (8(1)):54-62 doi:10.1177/2048872618782414.

    PMID: 29952633
  7. 7

    Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial.

    Ford TJ, Stanley B, Good R, et al.

    Journal of the American College of Cardiology 2018; (72(23 Pt A)):2841-2855 doi:10.1016/j.jacc.2018.09.006.

    PMID: 30266608
  8. 8

    Cardiovascular health and ovarian aging.

    Quinn MM, Cedars MI

    Fertility and sterility 2018; (110(5)):790-793 doi:10.1016/j.fertnstert.2018.07.1152.

    PMID: 30316413
  9. 9

    Metabolic Profile of Patients with Premature Ovarian Insufficiency.

    Podfigurna A, Stellmach A, Szeliga A, et al.

    Journal of clinical medicine 2018; (7(10)) doi:10.3390/jcm7100374.

    PMID: 30347864
  10. 10

    Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: Clinical features, treatment and 1 year follow-up.

    Abdu FA, Liu L, Mohammed AQ, et al.

    International journal of cardiology 2019; (287()):27-31 doi:10.1016/j.ijcard.2019.02.036.

    PMID: 30826195
  11. 11

    Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare population.

    Dreyer RP, Tavella R, Curtis JP, et al.

    European heart journal 2020; (41(7)):870-878 doi:10.1093/eurheartj/ehz403.

    PMID: 31222249
  12. 12

    Microvascular spasm in non-ST-segment elevation myocardial infarction without culprit lesion (MINOCA).

    Pirozzolo G, Seitz A, Athanasiadis A, et al.

    Clinical research in cardiology : official journal of the German Cardiac Society 2020; (109(2)):246-254 doi:10.1007/s00392-019-01507-w.

    PMID: 31236694
  13. 13

    Acute myocardial infarction in the setting of left bundle branch block: Chapman's sign.

    Idris A, Hatahet M, Edris B

    The American journal of emergency medicine 2019; (37(10)):1991.e5-1991.e7 doi:10.1016/j.ajem.2019.158378.

    PMID: 31395406
  14. 14

    The role of coronary reactivity testing in women with no obstructive coronary artery disease.

    AlBadri A, Mavromatis K, Bairey Merz CN

    Current opinion in cardiology 2019; (34(6)):656-662 doi:10.1097/HCO.0000000000000682.

    PMID: 31490202
  15. 15

    1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA).

    Ford TJ, Stanley B, Sidik N, et al.

    JACC. Cardiovascular interventions 2020; (13(1)):33-45 doi:10.1016/j.jcin.2019.11.001.

    PMID: 31709984
  16. 16

    Coronary Microvascular Dysfunction and Estrogen Receptor Signaling.

    Tunc E, Eve AA, Madak-Erdogan Z

    Trends in endocrinology and metabolism: TEM 2020; (31(3)):228-238 doi:10.1016/j.tem.2019.11.001.

    PMID: 31787492
  17. 17

    Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions.

    Vidal-Perez R, Abou Jokh Casas C, Agra-Bermejo RM, et al.

    World journal of cardiology 2019; (11(12)):305-315 doi:10.4330/wjc.v11.i12.305.

    PMID: 31908730
  18. 18

    Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study.

    Sidik NP, McEntegart M, Roditi G, et al.

    American heart journal 2020; (221()):48-59 doi:10.1016/j.ahj.2019.11.015.

    PMID: 31911341
  19. 19

    High-Resolution Late Gadolinium Enhancement Magnetic Resonance for the Diagnosis of Myocardial Infarction With Nonobstructed Coronary Arteries.

    Lintingre PF, Nivet H, Clément-Guinaudeau S, et al.

    JACC. Cardiovascular imaging 2020; (13(5)):1135-1148 doi:10.1016/j.jcmg.2019.11.020.

    PMID: 31954658
  20. 20

    Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.

    Paolisso P, Bergamaschi L, Saturi G, et al.

    Frontiers in pharmacology 2019; (10()):1606 doi:10.3389/fphar.2019.01606.

    PMID: 32082147
  21. 21

    Treatment of coronary microvascular dysfunction.

    Bairey Merz CN, Pepine CJ, Shimokawa H, Berry C

    Cardiovascular research 2020; (116(4)):856-870 doi:10.1093/cvr/cvaa006.

    PMID: 32087007
  22. 22

    Physiological Stratification of Patients With Angina Due to Coronary Microvascular Dysfunction.

    Rahman H, Demir OM, Khan F, et al.

    Journal of the American College of Cardiology 2020; (75(20)):2538-2549 doi:10.1016/j.jacc.2020.03.051.

    PMID: 32439003
  23. 23

    A noteworthy clue for diagnosing non-ST-elevation myocardial infarction by computed tomography without ECG synchronization: a case report.

    Nomura T, Tasaka S, Ono K, et al.

    BMC cardiovascular disorders 2020; (20(1)):244 doi:10.1186/s12872-020-01512-2.

    PMID: 32450798
  24. 24

    Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography.

    Zandecki L, Janion-Sadowska A, Kurzawski J, et al.

    PloS one 2020; (15(6)):e0234735 doi:10.1371/journal.pone.0234735.

    PMID: 32544195
  25. 25

    Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA).

    Tayal B, Freeman P, Ericsson F, et al.

    Acta cardiologica 2021; (76(7)):760-768 doi:10.1080/00015385.2020.1785134.

    PMID: 32594904
  26. 26

    An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.

    Kunadian V, Chieffo A, Camici PG, et al.

    European heart journal 2020; (41(37)):3504-3520 doi:10.1093/eurheartj/ehaa503.

    PMID: 32626906
  27. 27

    Cardiovascular magnetic resonance in myocardial infarction with non-obstructive coronary arteries patients: A review.

    Gatti M, Carisio A, D'Angelo T, et al.

    World journal of cardiology 2020; (12(6)):248-261 doi:10.4330/wjc.v12.i6.248.

    PMID: 32774777
  28. 28

    Functional coronary angiography in symptomatic patients with no obstructive coronary artery disease.

    Kumar S, Mehta PK, Eshtehardi P, et al.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2021; (98(5)):827-835 doi:10.1002/ccd.29237.

    PMID: 32902918
  29. 29

    The Imaging Toolbox to Assess Patients with Suspected Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA).

    Talebi S, Moreno P, Dominguez AC, Tamis-Holland JE

    Current cardiology reports 2020; (22(11)):134 doi:10.1007/s11886-020-01379-x.

    PMID: 32910364
  30. 30

    Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study.

    Lopez-Pais J, Izquierdo Coronel B, Galán Gil D, et al.

    Cardiology journal 2022; (29(5)):798-806 doi:10.5603/CJ.a2020.0146.

    PMID: 33140385
  31. 31

    Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.

    Reynolds HR, Maehara A, Kwong RY, et al.

    Circulation 2021; (143(7)):624-640 doi:10.1161/CIRCULATIONAHA.120.052008.

    PMID: 33191769
  32. 32

    Acute Chest Pain in Adults: Outpatient Evaluation.

    McConaghy JR, Sharma M, Patel H

    American family physician 2020; (102(12)):721-727.

    PMID: 33320506
  33. 33

    Diagnostic approach in patients with angina and no obstructive coronary artery disease: emphasising the role of the coronary function test.

    Konst RE, Damman P, Pellegrini D, et al.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2021; (29(3)):121-128 doi:10.1007/s12471-020-01532-9.

    PMID: 33415605
  34. 34

    Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

    Sörensson P, Ekenbäck C, Lundin M, et al.

    JACC. Cardiovascular imaging 2021; (14(9)):1774-1783 doi:10.1016/j.jcmg.2021.02.021.

    PMID: 33865778
  35. 35

    Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction.

    Godo S, Takahashi J, Yasuda S, Shimokawa H

    European cardiology 2021; (16()):e13 doi:10.15420/ecr.2020.47.

    PMID: 33897839
  36. 36

    The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.

    Pelliccia F, Pepine CJ, Berry C, Camici PG

    International journal of cardiology 2021; (336()):1-7 doi:10.1016/j.ijcard.2021.05.045.

    PMID: 34087335
  37. 37

    Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).

    Occhipinti G, Bucciarelli-Ducci C, Capodanno D

    European heart journal. Acute cardiovascular care 2021; (10(7)):813-822 doi:10.1093/ehjacc/zuab049.

    PMID: 34179954
  38. 38

    Pathophysiology and Diagnosis of Coronary Functional Abnormalities.

    Takahashi J, Suda A, Nishimiya K, et al.

    European cardiology 2021; (16()):e30 doi:10.15420/ecr.2021.23.

    PMID: 34603510
  39. 39

    Endothelium in Coronary Macrovascular and Microvascular Diseases.

    Godo S, Takahashi J, Yasuda S, Shimokawa H

    Journal of cardiovascular pharmacology 2021; (78(Suppl 6)):S19-S29 doi:10.1097/FJC.0000000000001089.

    PMID: 34840261
  40. 40

    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

    Mehta PK, Quesada O, Al-Badri A, et al.

    International journal of cardiology 2022; (348()):1-8 doi:10.1016/j.ijcard.2021.12.013.

    PMID: 34902504
  41. 41

    Diagnostic Value of Cardiac Magnetic Resonance Imaging and Intracoronary Optical Coherence Tomography in Patients With a Working Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries - A Systematic Review and Meta-analysis.

    Machanahalli Balakrishna A, Ismayl M, Thandra A, et al.

    Current problems in cardiology 2023; (48(6)):101126 doi:10.1016/j.cpcardiol.2022.101126.

    PMID: 35120967
  42. 42

    Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis.

    Mileva N, Nagumo S, Mizukami T, et al.

    Journal of the American Heart Association 2022; (11(7)):e023207 doi:10.1161/JAHA.121.023207.

    PMID: 35301851
  43. 43

    Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.

    Montone RA, Rinaldi R, Del Buono MG, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(8)):e666-e676 doi:10.4244/EIJ-D-21-00971.

    PMID: 35377315
  44. 44

    Interventional Diagnostic Procedure: a Practical Guide for the Assessment of Coronary Vascular Function.

    Ang DTY, Sidik NP, Morrow AJ, et al.

    Journal of visualized experiments : JoVE 2022; doi:10.3791/62265.

    PMID: 35377363
  45. 45

    Clinical Relevance of Ischemia with Nonobstructive Coronary Arteries According to Coronary Microvascular Dysfunction.

    Lee SH, Shin D, Lee JM, et al.

    Journal of the American Heart Association 2022; (11(9)):e025171 doi:10.1161/JAHA.121.025171.

    PMID: 35475358
  46. 46

    Phenotype-based management of coronary microvascular dysfunction.

    Ang DTY, Berry C, Kaski JC

    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2022; (29(6)):3332-3340 doi:10.1007/s12350-022-03000-w.

    PMID: 35672569
  47. 47

    ShareHeart: A patient journey map of patients with ischemia and non-obstructive coronary artery disease based on qualitative research.

    Van Schalkwijk DL, Widdershoven JWMG, Elias-Smale S, et al.

    Journal of clinical nursing 2023; (32(13-14)):3434-3444 doi:10.1111/jocn.16409.

    PMID: 35689371
  48. 48

    Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard Protocols.

    Takahashi T, Samuels BA, Li W, et al.

    Journal of the American College of Cardiology 2022; (79(24)):2367-2378 doi:10.1016/j.jacc.2022.03.385.

    PMID: 35710187
  49. 49

    Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries.

    Feenstra RGT, Boerhout CKM, Woudstra J, et al.

    Circulation. Cardiovascular interventions 2022; (15(8)):e012017 doi:10.1161/CIRCINTERVENTIONS.122.012017.

    PMID: 35904014
  50. 50

    A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

    Bastiany A, Pacheco C, Sedlak T, et al.

    CJC open 2022; (4(8)):709-720 doi:10.1016/j.cjco.2022.04.009.

    PMID: 36035733
  51. 51

    Coronary functional assessment in non-obstructive coronary artery disease: Present situation and future direction.

    Zhai C, Fan H, Zhu Y, et al.

    Frontiers in cardiovascular medicine 2022; (9()):934279 doi:10.3389/fcvm.2022.934279.

    PMID: 36082113
  52. 52

    Myocardial Infarction with Nonobstructive Coronary Arteries.

    Reynolds HR, Smilowitz NR

    Annual review of medicine 2023; (74()):171-188 doi:10.1146/annurev-med-042921-111727.

    PMID: 36179347
  53. 53

    One-Year Prospective Follow-up of Women With INOCA and MINOCA at a Canadian Women's Heart Centre.

    Parvand M, Cai L, Ghadiri S, et al.

    The Canadian journal of cardiology 2022; (38(10)):1600-1610 doi:10.1016/j.cjca.2022.07.005.

    PMID: 36202592
  54. 54

    Management of vasospastic angina.

    Beltrame JF

    Heart (British Cardiac Society) 2022; (109(1)):70-77 doi:10.1136/heartjnl-2022-321268.

    PMID: 36371661
  55. 55

    Updates on Pharmacologic Management of Microvascular Angina.

    Soleymani M, Masoudkabir F, Shabani M, et al.

    Cardiovascular therapeutics 2022; (2022()):6080258 doi:10.1155/2022/6080258.

    PMID: 36382021
  56. 56

    Myocardial infarction with non-obstructive coronary arteries (MINOCA).

    Yildiz M, Ashokprabhu N, Shewale A, et al.

    Frontiers in cardiovascular medicine 2022; (9()):1032436 doi:10.3389/fcvm.2022.1032436.

    PMID: 36457805
  57. 57

    Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-Analysis.

    Mileva N, Paolisso P, Gallinoro E, et al.

    JACC. Cardiovascular imaging 2023; (16(3)):376-389 doi:10.1016/j.jcmg.2022.12.029.

    PMID: 36889851
  58. 58

    Role of Intracoronary Imaging in Myocardial Infarction with Non-Obstructive Coronary Disease (MINOCA): A Review.

    Borzillo I, De Filippo O, Manai R, et al.

    Journal of clinical medicine 2023; (12(6)) doi:10.3390/jcm12062129.

    PMID: 36983131
  59. 59

    Invasive Coronary Assessment in Myocardial Ischemia with No Obstructive Coronary Arteries.

    Takahashi T, Gupta A, Samuels BA, Wei J

    Current atherosclerosis reports 2023; (25(10)):729-740 doi:10.1007/s11883-023-01144-9.

    PMID: 37682498
  60. 60

    Diseases of the Coronary Microcirculation: Diagnosis and Treatment.

    Ullrich-Daub H, Daub S, Olschewski M, et al.

    Deutsches Arzteblatt international 2023; (120(44)):739-746.

    PMID: 37721132
  61. 61

    Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think.

    Zdravkovic M, Popadic V, Klasnja S, et al.

    Medicina (Kaunas, Lithuania) 2023; (59(12)) doi:10.3390/medicina59122149.

    PMID: 38138252
  62. 62

    Early versus late cardiac magnetic resonance in the diagnosis of myocardial infarction with non-obstructive coronary arteries.

    Macedo Conde I, Salazar M, Pereira VH, et al.

    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2024; (43(7)):417-425 doi:10.1016/j.repc.2023.12.010.

    PMID: 38492801
  63. 63

    The invasive investigation of INOCA in the coronary catheterization lab.

    Burgess SN, Mamas MA

    American heart journal plus : cardiology research and practice 2024; (38()):100365 doi:10.1016/j.ahjo.2024.100365.

    PMID: 38510741
  64. 64

    Canadian Cardiovascular Society/Canadian Women's Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA).

    Pacheco C, Coutinho T, Bastiany A, et al.

    The Canadian journal of cardiology 2024; (40(6)):953-968 doi:10.1016/j.cjca.2024.02.032.

    PMID: 38852985
  65. 65

    Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications.

    Rinaldi R, Salzillo C, Caffè A, Montone RA

    Reviews in cardiovascular medicine 2022; (23(11)):371 doi:10.31083/j.rcm2311371.

    PMID: 39076191
  66. 66

    Acute coronary syndrome due to coronary vasospasm: a case report.

    Wang A, Meir J, Malik A, et al.

    Future cardiology 2024; (20(11-12)):613-618 doi:10.1080/14796678.2024.2392995.

    PMID: 39229652
  67. 67

    Long-term outcomes of ischaemia with no obstructive coronary artery disease (INOCA): a systematic review and meta-analysis.

    Odanović N, Schwann AN, Zhang Z, et al.

    Open heart 2024; (11(2)) doi:10.1136/openhrt-2024-002852.

    PMID: 39353703
  68. 68

    The Need for Separate Testing with Acetylcholine for the Assessment of Endothelial Dysfunction and Coronary Artery Spasm.

    Sueda S, Sakaue T

    European cardiology 2024; (19()):e17 doi:10.15420/ecr.2022.16.

    PMID: 39449721
  69. 69

    Invasive Evaluation for Coronary Vasospasm.

    Huang J, Steinberg R, Brown MJ, et al.

    US cardiology 2023; (17()):e07 doi:10.15420/usc.2022.33.

    PMID: 39493950
  70. 70

    Diagnostic Yield of Comprehensive Coronary Function Testing in Patients with Angina and Unobstructed Coronary Arteries: Endotype Characterisation and Clinical Implications.

    McChord J, Hubert A, Sechtem U, et al.

    European cardiology 2024; (19()):e19 doi:10.15420/ecr.2024.32.

    PMID: 39588253
  71. 71

    Exploring patients' views regarding the support and rehabilitation needs of people living with myocardial ischaemia and no obstructive coronary arteries: a qualitative interview study.

    Humphreys H, Paddock D, Brown S, et al.

    BMJ open 2024; (14(12)):e086770 doi:10.1136/bmjopen-2024-086770.

    PMID: 39658295
  72. 72

    Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis.

    Fedele D, Cavallo D, Bodega F, et al.

    Heart (British Cardiac Society) 2025; (111(7)):291-299 doi:10.1136/heartjnl-2024-324565.

    PMID: 39689931
  73. 73

    [Effects of Cardiac Rehabilitation on Symptoms and Quality of Life in Cardiopulmonary Exercise Test-Positive Patients With Non-Obstructive Coronary Artery Disease From High Altitudes].

    Che Q, Zhao L, Huang B, Li H

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2024; (55(6)):1507-1514 doi:10.12182/20241160107.

    PMID: 39990821
  74. 74

    Management of angina pectoris.

    Rinaldi R, Kunadian V, Crea F, Montone RA

    Trends in cardiovascular medicine 2025; (35(6)):341-350 doi:10.1016/j.tcm.2025.03.001.

    PMID: 40086653
  75. 75

    Intracoronary acetylcholine for vasospasm provocation in women with ischemia and no obstructive coronary artery disease.

    Tjoe B, Pacheco C, Suppogu N, et al.

    American heart journal plus : cardiology research and practice 2025; (53()):100527 doi:10.1016/j.ahjo.2025.100527.

    PMID: 40182421
  76. 76

    Clinical Effects of Supervised Cardiac Rehabilitation in Patients With Angina and Non-Obstructive Coronary Artery Disease and Impaired Myocardial Flow Reserve Assessed Using 13N-Ammonia Positron Emission Tomography.

    Miura S, Okizaki A, Kumamaru H, et al.

    Circulation journal : official journal of the Japanese Circulation Society 2025; (89(8)):1162-1171 doi:10.1253/circj.CJ-24-0128.

    PMID: 40301076
  77. 77

    Adherence to secondary preventive treatment following myocardial infarction with and without obstructive coronary artery disease.

    Nordenskjöld AM, Qvarnström M, Wettermark B, Lindahl B

    PloS one 2025; (20(5)):e0324072 doi:10.1371/journal.pone.0324072.

    PMID: 40408441
  78. 78

    Role of Cardiac Imaging in Myocardial Infarction With Non-Obstructive Coronary Arteries.

    Alonso AIB, Cabrero JB, Stojanovska J, et al.

    Echocardiography (Mount Kisco, N.Y.) 2025; (42(6)):e70198 doi:10.1111/echo.70198.

    PMID: 40444434
  79. 79

    Patient-Reported Symptoms of Acute Coronary Syndrome in the Prehospital Period in a Prospective Study: Implications for Emergency Nurse Triage, Diagnosis, and Clinical Outcomes.

    Zègre-Hemsey JK, Wong E, Crandell J, et al.

    Journal of emergency nursing 2025; (51(6)):1070-1083 doi:10.1016/j.jen.2025.04.016.

    PMID: 40455184
  80. 80

    Cardiac Rehabilitation for Patients With Ischemia and No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction With No Obstructive Coronary Arteries (MINOCA): A Review.

    Hausvater A, Reynolds HR

    Journal of cardiopulmonary rehabilitation and prevention 2025; (45(5)):311-317 doi:10.1097/HCR.0000000000000964.

    PMID: 40476778
  81. 81

    Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study.

    Rajwani A, Giudicatti L, Telyuk P, et al.

    Heart (British Cardiac Society) 2025; (112(2)):95-102 doi:10.1136/heartjnl-2024-325181.

    PMID: 40514208
  82. 82

    From Intracoronary Physiology to Endotype-Based Treatment: Quality of Life Improvement for INOCA Patients.

    Vitola B, Caunite L, Trusinskis K, et al.

    Journal of clinical medicine 2025; (14(20)) doi:10.3390/jcm14207192.

    PMID: 41156062
  83. 83

    Interplay of menopause, coronary artery calcium score and cardiovascular disease risk.

    Mishra T, Pasnoor DS, Gandhi M, et al.

    World journal of cardiology 2025; (17(11)):109627 doi:10.4330/wjc.v17.i11.109627.

    PMID: 41356582
  84. 84

    Sudden Death With Vasospastic Angina That Could Not Be Medically Managed.

    Emar M, Bhatty A

    Cureus 2025; (17(12)):e99544 doi:10.7759/cureus.99544.

    PMID: 41552237
  85. 85

    Exploring coronary microvascular dysfunction from functional impairment and structural damage.

    Wen W, Zhang Y, Jia G, Chi Y

    Frontiers in cardiovascular medicine 2025; (12()):1600947 doi:10.3389/fcvm.2025.1600947.

    PMID: 41696543
  86. 86

    Non-invasive and invasive diagnostic modalities for the assessment of coronary vasomotor dysfunction in ANOCA patients.

    Bijloo I, Woudstra J, Aribas E, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2026; (22(5)):e283-e291 doi:10.4244/EIJ-D-25-00250.

    PMID: 41770271
  87. 87

    MINOCA (Myocardial Infarction With Non-obstructive Coronary Arteries) Due to Diffuse Coronary Microvascular Dysfunction in a Patient With Systemic Autoimmune Disease and Chronic Kidney Disease.

    Kamboj T, Gill SS, Chopra N, Wander GS

    Cureus 2026; (18(2)):e103816 doi:10.7759/cureus.103816.

    PMID: 41869121
  88. 88

    Effect of State-of-the-Art Treatment on Symptoms, Absolute Coronary Artery Flow, and Resistance Among Patients With Ischemia and Non-Obstructive Coronary Arteries (STAR-INOCA Study): Study Design and Rationale.

    Zimmerli A, Buri J, Salihu A, et al.

    The American journal of cardiology 2026; (270()):76-80 doi:10.1016/j.amjcard.2026.04.026.

    PMID: 42009091
  89. 89

    Mental disorders, psychotropic drug dispensation and unfavourable sociodemographic factors in patients with myocardial infarction with and without obstructive coronary arteries.

    Nordenskjöld AM, Wirén A, Schef KW, et al.

    International journal of cardiology. Cardiovascular risk and prevention 2026; (29()):200639 doi:10.1016/j.ijcrp.2026.200639.

    PMID: 42058513
  90. 90

    Do menopausal symptoms signal early biological aging? Mitochondrial, endocrine and clinical insights.

    Blümel JE, Chedraui P, Vallejo MS

    Climacteric : the journal of the International Menopause Society 2026; (29(3)):358-363 doi:10.1080/13697137.2026.2663898.

    PMID: 42065350
  91. 91

    Feasibility and Impact of Invasive Coronary Function Testing in Ischemia and No Obstructive Coronary Arteries: A Single-Center Study.

    Acharya D, Alvarez YR, Samuels B, et al.

    Journal of the Society for Cardiovascular Angiography & Interventions 2026; (5(4)):104272 doi:10.1016/j.jscai.2026.104272.

    PMID: 42111098
  92. 92

    Comprehensive Endotyping of Patients With Angina and Nonobstructive Coronary Arteries: A Report From the J-CMD.

    Hada M, Kakuta T, Ueno H, et al.

    Journal of the American Heart Association 2026; (15(12)):e048016 doi:10.1161/JAHA.125.048016.

    PMID: 42261982
  93. 93

    Diagnostic Advancements in MINOCA: Do They Translate to a Better Clinical Outcome? A Review of the Literature.

    Bozika M, Apostolos A, Nastouli KM, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(7)) doi:10.3390/medicina62071243.

    PMID: 42512786
  94. 94

    Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management.

    El Khatib O, Al Azzoni A, Shantouf R, Atallah B

    Frontiers in cardiovascular medicine 2026; (13()):1811419 doi:10.3389/fcvm.2026.1811419.

    PMID: 42548607